C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/53 (2006.01) A61K 31/70 (2006.01) A61K 35/76 (2006.01) A61K 38/44 (2006.01) A61K 47/42 (2006.01) C12N 9/02 (2006.01) C12N 15/86 (2006.01) A61K 48/00 (2006.01)
Patent
CA 2175687
The system of the invention comprises: (i) a viral vector comprising a nucleotide sequence encoding a nitroreductase, which nitroreductase in capable of converting a prodrug into a cytotoxic drug; and (ii) a prodrug capable of being converted into a cytotoxic drug by the nitroreductase encoded by the vector.
Le système selon l'invention comprend : (i) un vecteur viral comprenant une séquence nucléotidique codant une nitroréductase, cette nitroréductase étant capable de transformer un précurseur de médicament en médicament cytotoxique; ainsi que (ii) un promédicament qui peut être transformé en médicament cytotoxique par la nitroréductase codée par ledit vecteur.
Connors Thomas
Knox Richard
Sherwood Roger
Cancer Research Campaign Technology Limited
Mccarthy Tetrault Llp
LandOfFree
A bacterial nitroreductase gene-prodrug system does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A bacterial nitroreductase gene-prodrug system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A bacterial nitroreductase gene-prodrug system will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1748653